Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Theradiag Names New Managers in Wake of Prestizia Acquisition

Premium

Theradiag this week announced several management changes in line with the strategic organization of the company into two divisions following last year's acquisition of microRNA technology firm Prestizia.

Specifically, Philippe Lestage will lead Theradiag's In Vitro Diagnostics division while Valery Labonne will lead the company's Theranostics division.

Lestage joins Theradiag from Ortho Clinical Diagnostics, a Johnson & Johnson company, where he most recently held the position of marketing director of transfusion medicine for Europe. As head of the IVD business unit he will be responsible for commercial operations, marketing, and customer service for France and international markets.

Labonne is a former marketing director for Boehringer Ingelheim and co-founder of StarGen Consulting. As head of the Theranostics division he will oversee domestic and international sales and marketing, Theradiag said.

Meantime, Odile Prigneau, previously vice president of marketing and business development at Theradiag, is now general manager of Prestizia, the subsidiary of Theradiag dedicated to microRNAs. Prigneau will retain her business development responsibilities within Theradiag and assist Labonne's marketing staff members in transitioning to their new responsibilities.

Theradiag also said that Eric Sallen, current director of sales, is leaving the company this month.

Filed under

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.